Project Details
Goal of the project
RESILIENCE-R-2023 aims to develop and test novel medical countermeasures (MCMs) against CBRNs in the framework of the three pillars of the RESILIENCE FPA multiannual action plan - Diagnosis, Prevention & Prophylaxis and Treatments. The project has the following objectives:
OB1) Design early and high-throughput diagnosis (point of care as well as reachback capabilities) of acute and late radiation-induced human health effects in preparedness of RN event,
OB2) Design of innovative decorporating and human decontaminating agents for NR threats,
OB3) Elaborate phage-based diagnostics and therapeutics for infections caused by CBRN relevant bacteria,
OB4) Design new generation vaccines against Monkeypox virus (MPXV) and Variola virus (VARV),
OB5) Design next generation of reactivators of cholinesterases against nerve agent intoxication.
Role of the organisation
Phage therapy research and production of therapeutic phage products, including facilities.
Funding acknowledgement
The Resilience-R project is financed by the European Commission through the European Defence Fund under grant 101168024
| Short title | First research action for Medical counter measures performed in the frame of the RESILIENCE FPA consortium |
|---|---|
| Acronym | RESILIENCE-R |
| Status | Active |
| Effective start/end date | 1/11/24 → 31/10/27 |
Collaborative partners
- Royal Military Academy
- Commissariat à l'Énergie Atomique (CEA) (lead)
- Agencia Estatal Consejo Superior de Investigaciones Cientificas
- Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento
- AIT Austrian Institute of Technology
- German Federal Institute for Risk Assessment
- Bundesamt für Strahlenschutz
- CNRS-Paris XI
- European Research Infrastructure on Highly Pathogenic Agents
- Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V.
- University of Helsinki
- Institute for Radiation Protection and Nuclear Safety
- Institut für Mikrobiologie der Bundeswehr
- Institut für Pharmakologie und Toxikologie der Bundeswehr
- Institut für Radiobiologie der Bundeswehr
- Institut national de la santé et de la recherche médicale
- Institut Pasteur, Paris
- Institut za medicinska istraživanja i medicinu rada
- Invitris GmbH
- JAFRAL
- Johann Wolfgang Goethe University
- KU Leuven
- University of Latvia
- MB Pharma
- microfluidic ChipShop
- Ministère des Armées
- The Netherlands Organisation for Applied Scientific Research
- Nemzeti Népegészségügyi Központ
- OPGS PHARMACEUTICALS
- Riga Stradiņš University
- Totalförsvarets Forskningsinstitut (Swedish Defence Research Agency)
- Campus UAB
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Université d'Orléans
- University of Rouen Normandy
- Université Paris Cité
- University of Ghent
- University of Hradec Králové
- Univerzita obrany
- Uniwersytet Gdański
- University of Wrocław
- Valneva SE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.